Pages that link to "Q6949366"
Jump to navigation
Jump to search
The following pages link to Myxoma virus (Q6949366):
Displayed 50 items.
- myxomatosis (Q1342455) (← links)
- (Q15676511) (redirect page) (← links)
- Leporipoxvirus (Q16948083) (← links)
- Evolutionary history and attenuation of myxoma virus on two continents (Q21558784) (← links)
- Myxoma virus M-T5 protects infected cells from the stress of cell cycle arrest through its interaction with host cell cullin-1 (Q24311311) (← links)
- Myxoma virus Serp2 is a weak inhibitor of granzyme B and interleukin-1beta-converting enzyme in vitro and unlike CrmA cannot block apoptosis in cowpox virus-infected cells (Q24527273) (← links)
- M-T5, the ankyrin repeat, host range protein of myxoma virus, activates Akt and can be functionally replaced by cellular PIKE-A (Q24672535) (← links)
- The α2,3-sialyltransferase encoded by myxoma virus is a virulence factor that contributes to immunosuppression (Q27312735) (← links)
- Myxoma virus immunomodulatory protein M156R is a structural mimic of eukaryotic translation initiation factor eIF2alpha (Q27639737) (← links)
- Structure of M11L: A myxoma virus structural homolog of the apoptosis inhibitor, Bcl-2 (Q27644227) (← links)
- Immunomodulation by viruses: the myxoma virus story (Q28139207) (← links)
- Inhibitory specificity of the anti-inflammatory myxoma virus serpin, SERP-1 (Q28278811) (← links)
- Myxoma virus expresses a secreted protein with homology to the tumor necrosis factor receptor gene family that contributes to viral virulence (Q28300302) (← links)
- Interruption of cytokine networks by poxviruses: lessons from myxoma virus (Q28302036) (← links)
- Comparative analysis of the complete genome sequence of the California MSW strain of myxoma virus reveals potential host adaptations (Q28390207) (← links)
- Co-regulation of NF-kappaB and inflammasome-mediated inflammatory responses by myxoma virus pyrin domain-containing protein M013 (Q28391594) (← links)
- Myxoma virus oncolytic efficiency can be enhanced through chemical or genetic disruption of the actin cytoskeleton (Q28538172) (← links)
- Prospects for fertility control in the European rabbit (Oryctolagus cuniculus) using myxoma virus-vectored immunocontraception (Q29030379) (← links)
- The Complete DNA Sequence of Myxoma Virus (Q29394705) (← links)
- Cellular factors promoting resistance to effective treatment of glioma with oncolytic myxoma virus. (Q30395978) (← links)
- M062 is a host range factor essential for myxoma virus pathogenesis and functions as an antagonist of host SAMD9 in human cells (Q30499249) (← links)
- Modulation of the myxoma virus plaque phenotype by vaccinia virus protein F11. (Q30524111) (← links)
- RIG-I mediates the co-induction of tumor necrosis factor and type I interferon elicited by myxoma virus in primary human macrophages (Q30845041) (← links)
- MALDI-TOF mass spectroscopy detects the capsid structural instabilities created by deleting the myxoma virus cupro-zinc SOD1 homolog M131R. (Q31121267) (← links)
- ELECTRON MICROSCOPIC STRUCTURE OF MYXOMA VIRUS AND SOME REACTIVABLE DERIVATIVES (Q33191914) (← links)
- Characterization of the major capsid proteins of myxoma virus particles using MALDI-TOF mass spectrometry (Q33225201) (← links)
- Early infections by myxoma virus of young rabbits (Oryctolagus cuniculus) protected by maternal antibodies activate their immune system and enhance herd immunity in wild populations. (Q33585153) (← links)
- Targeting gallbladder cancer: oncolytic virotherapy with myxoma virus is enhanced by rapamycin in vitro and further improved by hyaluronan in vivo (Q33613734) (← links)
- Oncolytic efficacy of recombinant vesicular stomatitis virus and myxoma virus in experimental models of rhabdoid tumors (Q33750535) (← links)
- Myxoma virus M141R expresses a viral CD200 (vOX-2) that is responsible for down-regulation of macrophage and T-cell activation in vivo (Q33780691) (← links)
- Serp2, an inhibitor of the interleukin-1beta-converting enzyme, is critical in the pathobiology of myxoma virus. (Q33784673) (← links)
- Horizontal transmissible protection against myxomatosis and rabbit hemorrhagic disease by using a recombinant myxoma virus. (Q33792968) (← links)
- Production of Myxoma virus gateway entry and expression libraries and validation of viral protein expression (Q33888269) (← links)
- Oncolytic viral purging of leukemic hematopoietic stem and progenitor cells with Myxoma virus (Q33895494) (← links)
- Biological effects of a de novo designed myxoma virus peptide analogue: evaluation of cytotoxicity on tumor cells. (Q34031478) (← links)
- Immunomodulatory proteins of myxoma virus (Q34209984) (← links)
- Myxoma virus leukemia-associated protein is responsible for major histocompatibility complex class I and Fas-CD95 down-regulation and defines scrapins, a new group of surface cellular receptor abductor proteins (Q34332353) (← links)
- A bioactive peptide analogue for myxoma virus protein with a targeted cytotoxicity for human skin cancer in vitro (Q34340401) (← links)
- Myxoma virus expressing a fusion protein of interleukin-15 (IL15) and IL15 receptor alpha has enhanced antitumor activity (Q34351517) (← links)
- Virotherapy using myxoma virus prevents lethal graft-versus-host disease following xeno-transplantation with primary human hematopoietic stem cells. (Q34384975) (← links)
- Study in the killing effect of Myxoma virus to C6 glioma cell in vitro (Q34392587) (← links)
- Myxoma virus M128L is expressed as a cell surface CD47-like virulence factor that contributes to the downregulation of macrophage activation in vivo (Q34421121) (← links)
- Infection of human cancer cells with myxoma virus requires Akt activation via interaction with a viral ankyrin-repeat host range factor. (Q34574890) (← links)
- A whole-genome RNA interference screen for human cell factors affecting myxoma virus replication (Q34585582) (← links)
- Immune responses to myxoma virus (Q34702782) (← links)
- Resistance to oncolytic myxoma virus therapy in nf1(-/-)/trp53(-/-) syngeneic mouse glioma models is independent of anti-viral type-I interferon. (Q34770256) (← links)
- Myxoma virus infection promotes NK lysis of malignant gliomas in vitro and in vivo. (Q34770719) (← links)
- Myxoma virus protein M029 is a dual function immunomodulator that inhibits PKR and also conscripts RHA/DHX9 to promote expanded host tropism and viral replication (Q34819569) (← links)
- A pox on thee! Manipulation of the host immune system by myxoma virus and implications for viral-host co-adaptation (Q34895045) (← links)
- Role of the serine-threonine kinase PAK-1 in myxoma virus replication (Q34976922) (← links)